Pfizer Inc.
PFE
$25.95
$0.160.62%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/29/2026 | 12/31/2025 | 09/28/2025 | 06/29/2025 | 03/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 63.31B | 62.58B | 62.79B | 63.83B | 62.46B |
| Total Other Revenue | 1.00M | -- | -1.00M | 0.00 | 0.00 |
| Total Revenue | 63.32B | 62.58B | 62.79B | 63.83B | 62.46B |
| Cost of Revenue | 15.95B | 15.14B | 16.59B | 17.48B | 16.75B |
| Gross Profit | 47.36B | 47.44B | 46.20B | 46.35B | 45.72B |
| SG&A Expenses | 12.95B | 13.02B | 14.03B | 14.06B | 14.33B |
| Depreciation & Amortization | 4.85B | 4.88B | 5.00B | 5.09B | 5.19B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.46B | 43.47B | 45.84B | 46.92B | 46.78B |
| Operating Income | 18.85B | 19.11B | 16.95B | 16.91B | 15.68B |
| Income Before Tax | 7.91B | 7.52B | 9.15B | 10.53B | 7.39B |
| Income Tax Expenses | 384.00M | -266.00M | -685.00M | -235.00M | -510.00M |
| Earnings from Continuing Operations | 7.52K | 7.79K | 9.84K | 10.77K | 7.90K |
| Earnings from Discontinued Operations | 12.00M | 25.00M | 32.00M | 24.00M | 16.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -43.00M | -41.00M | -41.00M | -40.00M | -29.00M |
| Net Income | 7.49B | 7.77B | 9.83B | 10.75B | 7.88B |
| EBIT | 18.85B | 19.11B | 16.95B | 16.91B | 15.68B |
| EBITDA | 25.40B | 25.66B | 23.63B | 23.68B | 22.56B |
| EPS Basic | 1.32 | 1.37 | 1.73 | 1.89 | 1.39 |
| Normalized Basic EPS | 2.04 | 2.07 | 1.68 | 1.63 | 1.49 |
| EPS Diluted | 1.31 | 1.36 | 1.72 | 1.89 | 1.39 |
| Normalized Diluted EPS | 2.03 | 2.07 | 1.67 | 1.62 | 1.49 |
| Average Basic Shares Outstanding | 22.75B | 22.73B | 22.71B | 22.69B | 22.68B |
| Average Diluted Shares Outstanding | 22.84B | 22.82B | 22.83B | 22.82B | 22.81B |
| Dividend Per Share | 2.15 | 2.15 | 2.13 | 2.12 | 2.11 |
| Payout Ratio | 97.92% | 94.29% | 73.88% | 66.94% | 121.49% |